Identification of acromegalic patients at risk of developing colonic adenomas

被引:37
作者
Bogazzi, F
Cosci, C
Sardella, C
Costa, A
Manetti, L
Gasperi, M
Rossi, G
Bartalena, L
Martino, E
机构
[1] Univ Pisa, Dept Endocrinol & Metab, I-56124 Pisa, Italy
[2] Univ Pisa, Dept Oncol, I-56124 Pisa, Italy
[3] CNR, Inst Clin Physiol, Unit Epidemiol & Biostat, I-56124 Pisa, Italy
[4] Univ Insubria, Dept Clin Med, I-21100 Varese, Italy
关键词
D O I
10.1210/jc.2005-2500
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Acromegaly seems to be associated with an increased prevalence of colonic adenomas, although factors affecting their development and recurrence of the latter are not fully known. Subjects and Methods: Seventy-nine patients with active acromegaly were prospectively followed up for 5 yr. Two hundred eighty healthy subjects served as controls. Colonoscopy and assessment of acromegaly activity were performed at 1-yr intervals. Acromegaly was defined as controlled if serum IGF-I levels were within the normal age-adjusted range. Results: Colonic adenomas were found in 26 of 79 acromegalic patients (32.9%) and 60 of 280 controls (21.4%) at baseline ( P = 0.035, adjusted for age and sex, odds ratio 1.82, 95% confidence interval, 1.02 - 3.25). Seven patients had hyperplastic polyps; the remaining 46 acromegalic patients had no detectable lesions at baseline and did not develop adenomas during the study period. Of the 26 patients with colonic adenomas at baseline, 16 ( 61.5%) had at least one recurrence of colonic adenomas ( P < 0.0001 vs. patients without colonic lesions at baseline), and multiple recurrences were more frequent in patients with uncontrolled acromegaly (66.7% vs. 17.6% in patients with controlled acromegaly, P = 0.028). Conclusions: The first colonoscopy helps to identify acromegalic patients at high risk of developing colonic adenomas. If colonic adenomas are not present initially, it is unlikely that they develop thereafter, independently of metabolic control of acromegaly. Conversely, new lesions are frequent ( and often multiple) in patients who already have colonic adenomas at baseline, particularly if acromegalic disease is poorly controlled by treatment.
引用
收藏
页码:1351 / 1356
页数:6
相关论文
共 29 条
[1]   Risk of colorectal neoplasia in acromegaly: an independent view [J].
Atkin, WS .
CLINICAL ENDOCRINOLOGY, 2001, 55 (06) :723-725
[2]   Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly [J].
Ayuk, J ;
Clayton, RN ;
Holder, G ;
Sheppard, MC ;
Stewart, PM ;
Bates, AS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04) :1613-1617
[3]   INCREASED SERUM DEOXYCHOLIC-ACID LEVELS IN MEN WITH COLORECTAL ADENOMAS [J].
BAYERDORFFER, E ;
MANNES, GA ;
RICHTER, WO ;
OCHSENKUHN, T ;
WIEBECKE, B ;
KOPCKE, W ;
PAUMGARTNER, G .
GASTROENTEROLOGY, 1993, 104 (01) :145-151
[4]   Apoptosis is reduced in the colonic mucosa of patients with acromegaly [J].
Bogazzi, F ;
Russo, D ;
Locci, MT ;
Chifenti, B ;
Ultimieri, F ;
Raggi, F ;
Cosci, C ;
Sardella, C ;
Costa, A ;
Gasperi, M ;
Bartalena, L ;
Martino, E .
CLINICAL ENDOCRINOLOGY, 2005, 63 (06) :683-688
[5]   Growth hormone inhibits apoptosis in human colonic cancer cell lines:: Antagonistic effects of peroxisome proliferator activated receptor-γ ligands [J].
Bogazzi, F ;
Ultimieri, F ;
Raggi, F ;
Russo, D ;
Vanacore, R ;
Guida, C ;
Brogioni, S ;
Cosci, C ;
Gasperi, M ;
Bartalena, L ;
Martino, E .
ENDOCRINOLOGY, 2004, 145 (07) :3353-3362
[6]   Growth hormone secretion in primary and secondary hyperparathyroidism [J].
Cecconi, E ;
Gasperi, M ;
Genovesi, M ;
Bogazzi, F ;
Grasso, L ;
Procopio, M ;
Marcocci, C ;
Pinchera, A ;
Bartalena, L ;
Martino, E .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2005, 28 (02) :113-116
[7]   Increased incidence of neoplasia in females with acromegaly [J].
Cheung, NW ;
Boyages, SC .
CLINICAL ENDOCRINOLOGY, 1997, 47 (03) :323-327
[8]   Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly [J].
Colao, A ;
Balzano, A ;
Ferone, D ;
Panza, N ;
Grande, G ;
Marzullo, P ;
Bove, A ;
Iodice, G ;
Merola, B ;
Lombardi, G .
CLINICAL ENDOCRINOLOGY, 1997, 47 (01) :23-28
[9]   CLINICAL REVIEW 18 - ARE PATIENTS WITH ACROMEGALY AT INCREASED RISK FOR NEOPLASIA [J].
EZZAT, S ;
MELMED, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (02) :245-249
[10]   Criteria for cure of acromegaly: A consensus statement [J].
Giustina, A ;
Barkan, A ;
Casanueva, FF ;
Cavagnini, F ;
Frohman, L ;
Ho, K ;
Veldhuis, J ;
Wass, J ;
Von Werder, K ;
Melmed, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) :526-529